Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells

• Rebekka Müller,

  Affiliation Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Kristine Misund ,

  Contributed equally to this work with: Kristine Misund, Toril Holien

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, K.G. Jebsen Center for Myeloma Research, Trondheim, Norway

  ⨯
• Toril Holien ,

  Contributed equally to this work with: Kristine Misund, Toril Holien

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, K.G. Jebsen Center for Myeloma Research, Trondheim, Norway

  ⨯
• Siri Bachke,

  Affiliation Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Karin M. Gilljam,

  Affiliation Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Thea K. Våtsveen,

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, K.G. Jebsen Center for Myeloma Research, Trondheim, Norway

  ⨯
• Torstein B. Rø,

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, K.G. Jebsen Center for Myeloma Research, Trondheim, Norway

  ⨯
• Emanuele Bellacchio,

  Affiliation Research Laboratories, Bambino Gesú Childreńs Hospital, IRCCS, Rome, Italy

  ⨯
• Anders Sundan,

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, K.G. Jebsen Center for Myeloma Research, Trondheim, Norway

  ⨯
• Marit Otterlei

  * E-mail: marit.otterlei@ntnu.no

  Affiliations Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway, APIM Therapeutics AS, Trondheim, Norway

  ⨯